Smith+Nephew agreed on 12 January to acquire Integrity Orthopaedics, a US developer of the Tendon Seam rotator cuff repair system, for US$225m in cash upfront and up to US$225m more in performance-based payments.
Why Smith & Nephew plc is buying Integrity Orthopaedics, Inc.
Smith+Nephew said the deal supports its RISE strategy and its aim of becoming the global leader in sports medicine. Tendon Seam uses patented micro-anchors, a continuous suture and individually locked stitches, and is intended to address structural failure rates of 20% to 40% seen with traditional repair techniques. It complements the REGENETEN bioinductive implant, the Q-FIX all-suture anchor and the AETOS shoulder system.
“Smith+Nephew now has an unrivalled portfolio for shoulder”
Deal terms and financing
The upfront payment is funded from existing cash facilities, keeping the group below its leverage target of 2x EBITDA. The additional payments of up to US$225m depend on performance over the next five years. Smith+Nephew expects the deal to add to group trading profit margin by 2028.
Regulatory approvals and timing
Smith+Nephew announced on 21 January 2026 that it had completed the acquisition of 100% of Integrity Orthopaedics.
Market context
Integrity Orthopaedics was founded in 2020 and is based in Maple Plain, Minnesota. Its co-founder and chief executive Tom Westling also co-founded Rotation Medical, which Smith+Nephew acquired in 2017. Tendon Seam received US 510(k) clearance in 2023. Smith+Nephew puts the US rotator cuff repair market at about 500,000 procedures and US$875m a year.
